InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Thursday, 03/17/2022 5:04:30 PM

Thursday, March 17, 2022 5:04:30 PM

Post# of 14947
I got a kick out of u/Henry's post about SEMDEXA...
" SEMDEXA: The 10-K confirms the complete six-months data analysis is expected this month and SRNE to submit request to FDA for Breakthrough Therapy Designation that will expedite NDA approval. Remember a 10-K is a very conservative document, there’s pages and pages of every imaginable risk, e.g. sky is falling, use 2 condoms, etc. While SRNE says they expect to submit a pre-NDA meeting request to FDA in 1H22, I still see FDA approval happening in late Q4. The opioid crisis because of the enormous death toll is foremost a political crisis and FDA responds to politics. Once SEMDEXA’s results become widely known thanks to publication in JAMA, NEJM, and the (4) major pain conferences Scilex will sponsor in 2022, don’t be surprised some morning NBC Today Show, etc. are talking about SEMDEXA! That’s when we know SRNE has arrived. The tiny hairline crack in the Hoover Dam suddenly starts to get bigger as the soccer moms (hydrostatic pressure) light up congressmen’s offices, who in turn pound the FDA, who are back blowin’ big pharma again (structural failure) when the dam bursts!! SEMDEXA NDA approval is about as sure a thing as we’ll ever see. Know what you own !!"

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News